Friday, 30 June 2017

Unichem Lab receives EIR report for Goa facility

Free Stock Tips

Two days Free Trials and best services packages for dealing in Stock market click here to get >> One Missed call on @9644405056

Leading pharma company, Unichem Laboratories Limited has said that the company’s formulations manufacturing facility at Goa has received an Establishment Inspection Report (EIR) from the USFDA. This receipt indicates the successful closure of the inspection and the queries raised during the audit (Form 483). The inspection has now been closed by the USFDA.

The inspection was carried out between 14th March 2017 to 20th March 2017. Unichem Laboratories manufactures and markets a large basket of pharmaceutical formulations as branded generics as well as generics in India and several other markets across the world.

No comments:

Post a Comment

Note: only a member of this blog may post a comment.